Memantine for Mitigation of Neurocognitive Toxicity Following Radiation to the Brain
Main Authors: | Danielle A. Cunningham, Paul D. Brown, Nadia N. I. Laack |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2021-12-01
|
Series: | JCO Global Oncology |
Online Access: | https://ascopubs.org/doi/10.1200/GO.20.00551 |
Similar Items
-
Memantine in the Prevention of Radiation-Induced Brain Damage: A Narrative Review
by: Claudia Scampoli, et al.
Published: (2022-05-01) -
Practice Patterns Related to Mitigation of Neurocognitive Decline in Patients Receiving Whole Brain Radiation Therapy
by: Vikram Jairam, MD, et al.
Published: (2022-07-01) -
Radiation-Induced Brain Injury: Age Dependency of Neurocognitive Dysfunction Following Radiotherapy
by: Claudia E. Rübe, et al.
Published: (2023-05-01) -
Memantine Modulates Oxidative Stress in the Rat Brain following Experimental Autoimmune Encephalomyelitis
by: Beata Dąbrowska-Bouta, et al.
Published: (2021-10-01) -
Memantine for dementia.
by: Mcshane, R, et al.
Published: (2006)